- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Pfizer (NYSE:PFE): Closing price $26.76
Pfizer might request an expedited review from the FDA for its treatment to slow a type of incurable breast cancer which is currently in Phase 2 trial, said Bloomberg, citing statements of Mikael Dolsten, head of worldwide research, who said at a JPMorgan conference that the firm has not yet reached a decision but is “obviously open to dialogues and advice from FDA and the European agencies regarding getting the drug to patients as soon as possible.”
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.